{
    "nctId": "NCT02186600",
    "officialTitle": "Randomized Control Trial of Bone Loading Exercises Versus Risedronate on Bone Health in Post-Menopausal Women",
    "inclusionCriteria": "* Women who are in their first 5 years of menopause\n* Have a T score between -1 and -2.49 at the femoral neck, total hip, or L1-L4 spine\n* Be 19 years of age or older\n* Have their health care provider's permission to enroll in the study.\n* Must be FEMALE\n* Must have minimum age of 19 Years",
    "exclusionCriteria": "* Have osteoporosis\n* Have a 10 yr probability of hip fracture \\>3% or major fracture \\>20% based on results of the fracture risk assessment (FRAX) tool\n* Currently take bisphosphonates, estrogen replacement therapy, glucocorticosteroids, or other drugs affecting bone\n* Currently participate in a resistance training or high impact weight bearing exercise program three or more times weekly\n* Weigh \\>300 lbs\n* Have abnormal results for the following laboratory tests: serum 25(OH)D; serum creatinine; serum calcium; parathyroid hormone (PTH); thyroid stimulating hormone (TSH).\n* Have Paget's disease, heart disease, uncontrolled hypertension, renal disease, or other concomitant conditions that prohibit participation in exercises, risedronate therapy, or use of CaD supplements."
}